Clinical Trial Update: Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating aspirin plus tea polyphenols for chemoprevention of esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Aspirin (Aspirin)
• Tea polyphenols (tea polyphenols)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Carcinoma, Squamous Cell | Phase 3 | Status: UNKNOWN